Functional impairment in social anxiety disorder

IM Aderka, SG Hofmann, A Nickerson… - Journal of anxiety …, 2012 - Elsevier
The present study examined functional impairment among treatment seekers with social
anxiety disorder (SAD). We investigated the effects of diagnostic subtypes of SAD and …

[HTML][HTML] The use and performance of productivity scales to evaluate presenteeism in mood disorders

N Despiégel, N Danchenko, C François, B Lensberg… - Value in Health, 2012 - Elsevier
Objective Mood disorders are associated with a high societal cost, mainly due to
presenteeism. The objective of this study was to review the use of 10 instruments that rate …

Generalized anxiety disorder

RB Hidalgo, DV Sheehan - Handbook of clinical neurology, 2012 - Elsevier
Generalized anxiety disorder (GAD) is common in clinical practice. Most cases are comorbid
with another Axis I disorder, notably mood disorders like major depressive disorder and …

Therapeutic Effects and Safety of Rhodiola rosea Extract WS® 1375 in Subjects with Life‐stress Symptoms – Results of an Open‐label Study

D Edwards, A Heufelder… - Phytotherapy …, 2012 - Wiley Online Library
The trial was conducted to investigate the therapeutic effects and safety of a 4 week
treatment with Rhodiola rosea extract WS® 1375 in subjects with life‐stress symptoms. This …

Multiscale assessment of treatment efficacy in adults with ADHD: a randomized placebo-controlled, multi-centre study with extended-release methylphenidate

W Retz, M Rösler, C Ose, A Scherag… - The World Journal of …, 2012 - Taylor & Francis
Objectives. This trial was performed to test the efficacy and safety of an extended-release
formulation of methylphenidate (MPH ER). Methods. A total of 162 adults with ADHD …

Vortioxetine (Lu AA21004) 5 mg in generalized anxiety disorder: results of an 8-week randomized, double-blind, placebo-controlled clinical trial in the United States

AJ Rothschild, AR Mahableshwarkar… - European …, 2012 - Elsevier
The goal of the current clinical study, conducted in the United States (US), was to evaluate
the efficacy and tolerability of vortioxetine 5mg vs placebo in adults with a primary diagnosis …

Vortioxetine (Lu AA21004) in the long-term open-label treatment of major depressive disorder

DS Baldwin, T Hansen, I Florea - Current medical research and …, 2012 - Taylor & Francis
Objective: The primary objective of this study was to evaluate the safety and tolerability of the
investigational drug vortioxetine (Lu AA21004) in the long-term treatment of patients with …

Patient education methods to support quality of life and functional ability among patients with schizophrenia: a randomised clinical trial

A Pitkänen, M Välimäki, L Kuosmanen, J Katajisto… - Quality of Life …, 2012 - Springer
Purpose The aim of this study was to estimate the effectiveness of patient education
methods on quality of life and functional impairment of patients with schizophrenia. Methods …

Assessing the relationship between functional impairment/recovery and depression severity: a pooled analysis

CJ Guico-Pabia, RS Fayyad… - International clinical …, 2012 - journals.lww.com
The objective of this study was to explore the relationship between assessments of
functional impairment, emotional well-being, and depression symptoms. Data were pooled …

Functional improvement and correlations with symptomatic improvement in adults with attention deficit hyperactivity disorder receiving long-acting methylphenidate

JK Buitelaar, M Casas, A Philipsen, JJS Kooij… - Psychological …, 2012 - cambridge.org
BackgroundData on the relationship between core symptoms and daily functioning in adults
with attention deficit hyperactivity disorder (ADHD) are limited. Daily functioning was …